Latest News

Hoboken, New Jersey – New research indicates that individuals with persistent and worsening metabolic syndrome—which encompasses conditions such as high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol—face an elevated risk of developing various types of cancer. The findings are published by Wiley online in CANCER, a...
Dogs always have been known as man’s best friend, but when it comes to seizure-response dogs for those with epilepsy, these special canines become invaluable protectors. The Walker family in north suburban Grayslake — mom Candace and children Colin, 11, Carson, 9, and Cailean, 5 — know this all too...
POWAY — A Poway man afflicted with a life-threatening skin disease has passed a major obstacle on his way to an experimental stem-cell treatment. Mark Buenconsejo, 51, already has raised money with fundraisers and has successfully fought an insurance company that originally had refused to cover the expenses for a...
STAMFORD, Conn. – Dr. James M. Wilson and Alex Karnal announced today the launch of The Institute for Life Changing Medicines, a nonprofit organization, with a mission of identifying, developing and promoting access to therapies that have transformative potential but are not considered commercially viable because they are designed to...
ROCHESTER, Minn. — Two Mayo Clinic patients whose prostate cancer had been considered inoperable are now cancer free thanks in part to an experimental drug therapy that was used in combination with standardized hormone treatment and radiation therapy. The men were participating in a clinical trial of an immunotherapeutic agent...
Ann Arbor, Mich. – Over the last decade, research at Michigan Medicine has shown how exposure to toxins in the environment, such as pesticides and carcinogenic PCBs, affect the risk of developing and dying from amyotrophic lateral sclerosis. Now, investigators have developed an environmental risk score that assesses a person’s risk...
PARIS, France – In a groundbreaking endeavour set to span five years, the DREAMS consortium is paving the way for a novel approach to treating neuromuscular diseases. This transformative project merges the power of artificial intelligence, pluripotent stem cells, and cutting-edge pharmacological screening techniques to seek out therapeutic solutions for...